chr14-36516817-CA-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
The NM_001079668.3(NKX2-1):c.*460del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.12 ( 1408 hom., cov: 0)
Exomes 𝑓: 0.19 ( 32 hom. )
Consequence
NKX2-1
NM_001079668.3 3_prime_UTR
NM_001079668.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.44
Genes affected
NKX2-1 (HGNC:11825): (NK2 homeobox 1) This gene encodes a protein initially identified as a thyroid-specific transcription factor. The encoded protein binds to the thyroglobulin promoter and regulates the expression of thyroid-specific genes but has also been shown to regulate the expression of genes involved in morphogenesis. Mutations and deletions in this gene are associated with benign hereditary chorea, choreoathetosis, congenital hypothyroidism, and neonatal respiratory distress, and may be associated with thyroid cancer. Multiple transcript variants encoding different isoforms have been found for this gene. This gene shares the symbol/alias 'TTF1' with another gene, transcription termination factor 1, which plays a role in ribosomal gene transcription. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.265 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NKX2-1 | NM_001079668.3 | c.*460del | 3_prime_UTR_variant | 3/3 | ENST00000354822.7 | ||
SFTA3 | NR_161364.1 | n.89+2650del | intron_variant, non_coding_transcript_variant | ||||
NKX2-1 | NM_003317.4 | c.*460del | 3_prime_UTR_variant | 2/2 | |||
SFTA3 | NR_161365.1 | n.89+2650del | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NKX2-1 | ENST00000354822.7 | c.*460del | 3_prime_UTR_variant | 3/3 | 1 | NM_001079668.3 | P4 | ||
NKX2-1 | ENST00000498187.6 | c.*460del | 3_prime_UTR_variant | 2/2 | 1 | A1 | |||
ENST00000634305.1 | n.322+67995del | intron_variant, non_coding_transcript_variant | 5 | ||||||
NKX2-1 | ENST00000518149.5 | c.*460del | 3_prime_UTR_variant | 3/3 | 5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.123 AC: 17430AN: 142196Hom.: 1398 Cov.: 0
GnomAD3 genomes
AF:
AC:
17430
AN:
142196
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.194 AC: 13891AN: 71702Hom.: 32 Cov.: 0 AF XY: 0.191 AC XY: 6304AN XY: 32964
GnomAD4 exome
AF:
AC:
13891
AN:
71702
Hom.:
Cov.:
0
AF XY:
AC XY:
6304
AN XY:
32964
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.123 AC: 17470AN: 142256Hom.: 1408 Cov.: 0 AF XY: 0.129 AC XY: 8883AN XY: 68814
GnomAD4 genome
AF:
AC:
17470
AN:
142256
Hom.:
Cov.:
0
AF XY:
AC XY:
8883
AN XY:
68814
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Brain-lung-thyroid syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign hereditary chorea Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at